Phase 1 Pancreatic Cancer Trial, Recruiting NCT06639724 Sponsor: University of California, San Diego Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Phase 1 Pancreatic Cancer Trial, Recruiting

NCT06639724
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to understand and are willing to sign a consent form agreeing to take part in the study.
  • You are 18 years of age or older.
  • You are generally healthy enough to be active and care for yourself, with only minor limitations on physical activity (confirm with trial site).
  • A surgeon has confirmed within the past 28 days that you are a suitable candidate for surgery.
  • You have been diagnosed with pancreatic cancer (a type called PDAC) that doctors believe can be fully removed by surgery, based on a CT or MRI scan taken within the last 4 weeks showing the cancer has not spread to nearby major blood vessels or to other parts of the body.
  • Your blood counts, liver, and kidney are working well enough, based on recent blood tests (confirm with trial site for specific numbers).
  • If you can become pregnant, you must be willing to use highly effective birth control for at least 2 weeks before joining and throughout the study.
  • If you can cause a pregnancy, you must be willing to use condoms or other reliable contraception with your partner throughout the study.

Who may not be able to join:

  • You have already received any treatment for your pancreatic cancer.
  • Your pancreatic cancer has come back after previous treatment or has spread to other parts of the body.
  • You have significant nerve damage causing weakness, numbness, or pain (above a moderate level — confirm with trial site).
  • You have taken part in another experimental drug study within the past 28 days.
  • You have an active Hepatitis B infection, or a currently active Hepatitis C infection (people with past Hepatitis C exposure may still be eligible if a follow-up test confirms the virus is no longer active — confirm with trial site).
  • You currently have an active infection that requires treatment with antibiotics or other medicines given throughout the body.
  • You have a known mental health condition or substance use problem that might make it difficult to follow the study requirements.
  • You have previously received a transplanted organ or bone marrow from a donor.
  • You have had a major surgery within the past 28 days.
  • You are unwilling or unable to stop taking any medications or treatments that are not allowed during the study.
  • You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Andrew Lowy, MD, UCSD

Phone: 858-822-5354

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Registry
ClinicalTrials.gov
Start date
5 December 2024
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Surgical delay

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov